ArticlePharmaceuticals (Basel, Switzerland)2021

Discovery and Characterization of a Novel MASTL Inhibitor MKI-2 Targeting MASTL-PP2A in Breast Cancer Cells and Oocytes.

Minsung Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.